Minze Health
Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.
Clouds of care
Venture Round in 2024
Clouds of Care is a consulting firm that supports HealthTech companies throughout their development journey, from algorithm validation to medical device software. The company specializes in regulatory compliance and aims to identify and eliminate go-to-market barriers that can hinder the introduction of innovative technologies. By leveraging its expertise in quality assurance and regulatory requirements, as well as software development, Clouds of Care enables HealthTech firms to expedite the delivery of their solutions to patients, fostering advancements in healthcare technology.
neuroClues
Seed Round in 2024
neuroClues is a medical technology company that aims to revolutionize the diagnosis of neurological disorders by providing an innovative eye-tracking platform. This technology allows practitioners to easily and quickly quantify clinical exams by extracting eye movement biomarkers. By enabling neurologists to identify Parkinsonian syndromes and other central nervous system disorders years before visible symptoms appear, neuroClues supports early detection and monitoring of these conditions. The company's non-invasive approach offers a simple and robust method for both healthcare professionals and patients to track neurological health, enhancing the ability to manage and understand these complex diseases over time.
Axithra
Seed Round in 2023
Axithra is a healthcare company that specializes in therapeutic medication monitoring, particularly focusing on beta-lactam antibiotics. It has developed a platform that leverages proprietary optical and photonics technology to enable rapid and accurate measurement of drug concentrations in the blood. This innovative approach facilitates the personalization of antibiotic treatments in intensive care settings, allowing healthcare providers to tailor therapies to meet the specific needs of individual patients. By providing precise measurements, Axithra aims to enhance patient care and optimize treatment outcomes for those receiving beta-lactam antibiotics.
Minze Health
Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.
Intressa Vascular
Funding Round in 2022
Intressa Vascular is a medical technology company focused on developing advanced solutions for cardiovascular conditions, particularly aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for endovascular treatment. This innovative approach enables physicians to effectively address the severe impacts of aortic dissections while minimizing the risk of ischemic complications. Through collaborative efforts and a commitment to high-quality product development, Intressa Vascular aims to enhance patient care and improve clinical outcomes in the treatment of cardiovascular diseases.
Bingli is a healthcare technology company that specializes in developing applications aimed at improving communication between patients and doctors. The company's application conducts smart pre-consultation interviews with patients, enabling them to accurately convey their symptoms to healthcare providers. This process ensures that patients are better prepared for their consultations, while also allowing doctors to save time during appointments. By facilitating more effective information sharing, Bingli aims to enhance the overall quality of healthcare delivery.
MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.
Endo Tools Therapeutics
Series D in 2021
Endo Tools Therapeutics S.A., established in 2008 and based in Gosselies, Belgium, is a medical device company focused on creating innovative devices for gastroenterologists. The company develops therapeutic devices that enhance interventional gastroenterology, including a triangulation platform known as ENDOMINA. This open platform enables gastroenterologists to perform a variety of therapeutic procedures more effectively. Endo Tools Therapeutics is also working on a catheter designed to provide additional therapeutic channels and enhanced maneuverability during interventions. The company's products aim to improve treatment options for conditions such as obesity, digestive tract tumors, and diabetes by facilitating flexible endoscopic suturing and tissue apposition, thereby enabling more efficient surgical endoscopy.
Antelope Dx
Series B in 2020
Antelope Dx BV is a Belgian company founded in 2018, focused on developing innovative diagnostic solutions for home testing and point-of-care applications. The company has created a palm-sized diagnostic device that utilizes lab-on-chip technology, allowing users to conduct high-quality tests on various bodily fluids without the need for complex procedures or sample preparation. Among its offerings is the Antelope Diagnostic STD-Test, a urine-based self-test for detecting common sexually transmitted diseases, including Chlamydia trachomatis and Neisseria gonorrhoeae. Antelope Dx aims to enhance accessibility to essential health diagnostics for consumers, healthcare professionals, and sectors such as animal health and drug development. Based in Zwijnaarde, Belgium, the company is committed to advancing the field of diagnostics through user-friendly and effective testing solutions.